Evidence that increased azole persistence and stress resistance precede the in vivo evolution of azole resistance in Aspergillus fumigatus
Microbiology Spectrum · 07.04.2026 · 14 (4)
DOI: 10.1128/spectrum.04021-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 07.04.2026. Verfasst von Endrews Delbaje und 14 weiteren Autor:innen. Beteiligte Einrichtung: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirao Preto, Brazil. Hauptthemen laut MEDLINE: Aspergillus fumigatus, Antifungal Agents, Drug Resistance, Fungal, Azoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Aspergillus fumigatus is the major causative agent of human aspergillosis. Azoles are the first-line therapy, but resistance is increasing. Here, we characterized voriconazole persistence by screening a global collection of 495 clinical and environmental A. fumigatus isolates. We demonstrate two persistence phenotypes: non-growth persisters (NGPs) and slow-growth persisters (SGPs). We focused on nine sequential clinical isolates from a single patient treated with voriconazole for 2 years. Genome sequencing and phylogenomic analyses show that these isolates form a single genetically related population exhibiting within-host diversification. While temporal isolation order does not strictly correlate with genetic relatedness, we observe that increased azole persistence and stress resistance are early adaptive steps in the in vivo evolution of azole resistance, preceding the emergence of voriconazole resistance. Our findings indicate that increased persistence and stress resistance may create a permissive adaptive landscape within the host, highlighting the complex evolutionary dynamics underlying antifungal treatment failure. IMPORTANCE Azole resistance in Aspergillus fumigatus is a major clinical concern; however, treatment failures occur without the presence of classic resistance mutations. This study provides evidence that azole persistence—the ability of susceptible cells to survive drug exposure—and stress resistance precede the in vivo evolution of azole resistance in Aspergillus fumigatus . We identified two persistence types in a global isolate collection and tracked their evolution in a patient over a 2-year period. Our findings reveal that increased voriconazole persistence and stress resistance emerged before the acquisition of the cyp51A resistance mutation. This adaptive phase involved significant transcriptional and metabolic reprogramming, including the upregulation of secondary metabolism. We propose that persistence is not a passive survival state, but an active evolutionary stepping stone that fosters a permissive landscape for the development of resistance. Understanding this “persistence-first” pathway is crucial for developing more effective diagnostics and therapeutic strategies to combat antifungal treatment failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirao Preto, Brazil.
- Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
- Diagnosic and Research Institute for Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria.
- Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California, USA.
- Clinical and Translational Fungal Working Group, University of California San Diego, La Jolla, California, USA.
- Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
ORCID-Profile: Endrews Delbaje, Sarah Sedik, Cornelia Lass-Flörl, Cristina Silva Pereira, Angélica Zaninelli Schreiber, Antonis Rokas, Ling Lu, Júlio César Jeronimo Barbosa, Gustavo H Goldman
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Delbaje, E., Pontes, L., Savoldi, M., Sedik, S., Dichtl, K., Hoenigl, M., Lass-Flörl, C., Silva Pereira, C., Schreiber, A. Z., Rokas, A., Lu, L., Barbosa, J. C. J., Fill, T., Dos Reis, T. F., & Goldman, G. H. (2026). Evidence that increased azole persistence and stress resistance precede the in vivo evolution of azole resistance in Aspergillus fumigatus. Microbiology Spectrum, 14(4). https://doi.org/10.1128/spectrum.04021-25
Vancouver
Delbaje E, Pontes L, Savoldi M, Sedik S, Dichtl K, Hoenigl M, et al. Evidence that increased azole persistence and stress resistance precede the in vivo evolution of azole resistance in Aspergillus fumigatus. Microbiology Spectrum. 2026;14(4). doi:10.1128/spectrum.04021-25
BibTeX
@article{Delbaje2026,
author = {Delbaje, Endrews and Pontes, Laís and Savoldi, Marcela and Sedik, Sarah and Dichtl, Karl and Hoenigl, Martin and Lass-Flörl, Cornelia and Silva Pereira, Cristina and Schreiber, Angélica Zaninelli and Rokas, Antonis and Lu, Ling and Barbosa, Júlio César Jeronimo and Fill, Taícia and Dos Reis, Thaila Fernanda and Goldman, Gustavo H},
title = {Evidence that increased azole persistence and stress resistance precede the in vivo evolution of azole resistance in Aspergillus fumigatus},
journal = {Microbiology Spectrum},
year = {2026},
volume = {14},
number = {4},
doi = {10.1128/spectrum.04021-25}
}
EUVIMED